3D Printed Drugs Market Is Anticipated To Witness Lucrative Growth In The Near Future Till 2024

Press Release

The 3D Printed Drugs market is anticipated to witness lucrative growth in the near future. The ease of ingestion of drug for the patients suffering from several diseases causing seizures such as epilepsy, medicinal intake by old age and infants are several applications of 3D printed drugs effecting the 3D Printed Drugs market in forth coming years
Asia Pacific is slated to account for a leading share of 34.1% by 2024 in the 3D printed drugs market and expected to witness lucrative growth over the forecast period i.e. 2018-2024 by registering a CAGR of 18.2% over the forecast period. Further, the market is expected to account for USD 532 Million by 2024 from USD 142.8 Million in 2016. This can be attributed to the robust expansion of pharmaceutical industries in this the region on the back of positive GDP figures. Further, rising adoption of advanced healthcare technologies by consumers on the back of swelled disposable income is expected to positively drive the growth of the market.

Download/Request Sample Copy of Strategic Report:
https://www.kennethresearch.com/sample-request-10049517

In addition to this, China 3D printed drugs market was held at USD 67.3 Million in 2016 and is anticipated to reach USD 252 Million by the end of 2024. China 3D printed drugs market accounted for a market share of 47.17% in 2016 and further, is expected to increase to a market share of 47.37% by the end of 2024.

Key Players

FabRx Ltd. Technologies Inc., Aprecia Pharmaceuticals, LLC. are the only players of 3D printed drugs market and GlaxoSmithKline (gsk) is considered to be a potential player as the organization is contemplating to invest considerably in the industry

North America 3D printed drugs market expected to witness lucrative growth over the forecast period i.e. 2018-2024 by registering a CAGR of 19.4% over the forecast period Global 3D printed drugs market is segmented on the basis of application into orthopedic, neurology, hearing & audibility aid, medical implants, dental and others. Among these segments, Neurology segment (37.1% share in 2016) occupies the largest market of 3D printed drugs across the globe. Further, global Neurology segment is anticipated to reach USD 594.6 Million by the end of 2024 from USD 156.6 Million in 2016

Talk To Analyst for Customization of Strategic Report and Grab Discount on Purchase:
https://www.kennethresearch.com/customization-request-10049517

About Kenneth Research:

Kenneth Research provides market research reports to different individuals, industries, associations and organizations with an aim of helping them to take prominent decisions. Our research library comprises of more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both macro level as well as micro level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis on various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keep a track on the international and domestic market for any economic changes impacting the products’ demand, growth and opportunities for new and existing players.

Contact Us

Kenneth Research

Email: [email protected]

Phone: +1 313 462 0609

<<<<<Trending New Reports From Healthcare Industry>>>>>

New Report
New Report
New Report
New Report
New Report
New Report
New Report
New Report
New Report
New Report